Oxaliplatin 100 MG

DRUG2 trials

Sponsors

University Hospital Southampton NHS Foundation Trust, Fudan University

Conditions

Diffuse Large B Cell LymphomaPancreatic CancerRefractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B-Cell Lymphoma

Phase 2

Atezolizumab, Rituximab, Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory DLBCL Not Suitable for High-dose Therapy

TerminatedNCT03422523

University Hospital Southampton NHS Foundation TrustDiffuse Large B Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Relapsed Diffuse Large B-Cell Lymphoma

Start: 2018-05-09End: 2021-11-18Updated: 2022-08-22

Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer

RecruitingNCT06475326

Fudan UniversityPancreatic Cancer

Start: 2024-06-05End: 2025-12-31Target: 87Updated: 2024-08-09